Mental Health

Laguna Treatment Center Strengthens Clinical Team with New Behavioral Health Therapist

Behavioral Health Therapist Tanya L. Hauer, MSW, ACSW Laguna Treatment Center, a leading drug and alcohol rehab in Orange County,…

1 month ago

New Year, New Mission: Oxford Treatment Center Empowers Veterans to Reclaim Their Lives in 2026

ETTA, Miss., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Veterans face substance use disorders at disproportionately high rates. More than one…

1 month ago

The Benefits of Restorative Programming for Skilled Nursing Facilities

KENNESAW, GA / ACCESS Newswire / December 30, 2025 / When we picture ourselves or our loved ones aging, we…

1 month ago

LG NOVA UNVEILS NEXT GENERATION OF AI-FIRST VENTURES AT CES 2026

Collaborative AI-First Ventures Delivers Impactful Solutions for Health, Energy, Small Business and Enterprise SectorsLAS VEGAS, Dec. 29, 2025 /PRNewswire/ -- LG…

1 month ago

QHSLab, Inc. (OTCQB:USAQ) Completes $500K Private Placement, Enters 2026 With Clean Capital Structure

With legacy overhang removed and new capital secured, management shifts focus from balance-sheet repair to disciplined growth execution. West Palm…

1 month ago

BioSonic Bloom: What Published Research Says About 528 Hz and 432 Hz Audio Frequency Programs

An In-Depth Analysis of Digital Sound Frequency Programs, Binaural Beats Research, and Key Considerations for 2026Detroit, MI, Dec. 27, 2025…

1 month ago

Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support

LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) -- This holiday season, addiction experts at Desert Hope Treatment Center are encouraging individuals…

1 month ago

Clearmind Medicine Reflects on a Transformative 2025: Key Clinical Advancements, Expanded Global Reach, and Strengthened Foundation for Future Growth

Vancouver, Canada, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

1 month ago

Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia

Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through…

1 month ago

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)

NEW YORK and AMSTERDAM, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage…

2 months ago